Status:
COMPLETED
Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Conditions:
Sars-CoV2
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The study evaluates the distribution of immunological and virological profiles of newborns patients. Mothers of these children have a proven infection to SARS Cov-2 during pregnancy.
Eligibility Criteria
Inclusion
- pregnant woman
- diagnosed with Sars Cov-2 during pregnancy
- singleton or twin pregnancy
- informed consent
Exclusion
- virological or serological samples not done the day of delivery
Key Trial Info
Start Date :
May 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 2 2021
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04402918
Start Date
May 17 2020
End Date
August 2 2021
Last Update
August 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Besancon
Besançon, France, 25000